110 related articles for article (PubMed ID: 12356115)
21. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.
Donadieu J; Leblanc T; Bader Meunier B; Barkaoui M; Fenneteau O; Bertrand Y; Maier-Redelsperger M; Micheau M; Stephan JL; Phillipe N; Bordigoni P; Babin-Boilletot A; Bensaid P; Manel AM; Vilmer E; Thuret I; Blanche S; Gluckman E; Fischer A; Mechinaud F; Joly B; Lamy T; Hermine O; Cassinat B; Bellanné-Chantelot C; Chomienne C;
Haematologica; 2005 Jan; 90(1):45-53. PubMed ID: 15642668
[TBL] [Abstract][Full Text] [Related]
22. [Acute retinal necrosis in an acute leukemia pediatric patient].
Torres T JP; Concha V E; López G JP; Cofre G J
Rev Chilena Infectol; 2007 Aug; 24(4):323-6. PubMed ID: 17728923
[TBL] [Abstract][Full Text] [Related]
23. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow colony-stimulating activity in sera of children with acute leukemia. A sequential analysis.
Foster RS; Metcalf D; Cortner J
Cancer; 1971 Apr; 27(4):881-6. PubMed ID: 5280375
[No Abstract] [Full Text] [Related]
25. Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review.
Bhana N
Curr Opin Oncol; 2007 Jul; 19(4):328-35. PubMed ID: 17545795
[TBL] [Abstract][Full Text] [Related]
26. [Effectiveness of Leukostim, a Russian preparation of granulocyte colony-stimulating factor, in the treatment of chemotherapy-induced neutropenia in patients with malignant tumors].
Korman DB; Boronovskaia LE; Maslova IA; Andreeva EV; Seregina GV
Vopr Onkol; 2008; 54(5):639-42. PubMed ID: 19069482
[TBL] [Abstract][Full Text] [Related]
27. An unusual case of reactive lymphocytosis mimicking acute leukemia.
Yetgin S; Kuskonmaz B; Aytaç S; Tavil B
Pediatr Hematol Oncol; 2007 Mar; 24(2):129-35. PubMed ID: 17454779
[TBL] [Abstract][Full Text] [Related]
28. Pancytopenia associated with varicella.
Kyong CU; Darby CP; Malcolm RJ
Br J Clin Pract; 1979 Oct; 33(10):299-300. PubMed ID: 526419
[No Abstract] [Full Text] [Related]
29. Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry.
Beaupain B; Leblanc T; Reman O; Hermine O; Vannier JP; Suarez F; Lutz P; Bordigoni P; Jourdain A; Schoenvald M; Ouachee M; François S; Kohser F; Jardin F; Devouassoux G; Bertrand Y; Nove-Josserand R; Donadieu J;
Pediatr Blood Cancer; 2009 Dec; 53(6):1068-73. PubMed ID: 19618456
[TBL] [Abstract][Full Text] [Related]
30. Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
Skarlos DV; Timotheadou E; Galani E; Samantas E; Grimani I; Lianos E; Aravantinos G; Xanthakis I; Pentheroudakis G; Pectasides D; Fountzilas G
Oncology; 2009; 77(2):107-12. PubMed ID: 19622901
[TBL] [Abstract][Full Text] [Related]
31. Granulocytic growth factors and cancer-related neutropenia: limited effects.
Prescrire Int; 2006 Oct; 15(85):189-91. PubMed ID: 17128529
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyolysis due to Escherichia coli sepsis in three pediatric patients with acute lymphoblastic leukemia.
Yilmaz S; Demircioğlu F; Oren H; Güneş B; Irken G
Pediatr Hematol Oncol; 2009 Mar; 26(2):57-62. PubMed ID: 19322735
[TBL] [Abstract][Full Text] [Related]
33. Pegfilgrastim use during chemotherapy: current and future applications.
Wolf T; Densmore JJ
Curr Hematol Rep; 2004 Nov; 3(6):419-23. PubMed ID: 15496275
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic use of granulocyte colony-stimulating factor after chemotherapy does not affect survival rate in acute myeloid leukemia: a meta-analysis.
Wang J; An L; Chen S; Ouyang J; Zhou R; Chen B; Yang Y
Acta Haematol; 2009; 121(4):223-6. PubMed ID: 19546524
[No Abstract] [Full Text] [Related]
35. Granulocyte colony-stimulating factor use in patients with chemotherapy-induced neutropenia: clinical and economic benefits.
Rader M
Oncology (Williston Park); 2006 Apr; 20(5 Suppl 4):16-21. PubMed ID: 16736984
[TBL] [Abstract][Full Text] [Related]
36. The use of recombinant human activated protein C (rhAPC) in the treatment of severe sepsis in immunosuppressed patients in the course of hematological diseases.
Kunsdorf-Wnuk A; Marzec-Lewenstein E; Arct-Danielak D; Musioł E; Bohatyrewicz R; Becht R
Med Sci Monit; 2005 Aug; 11(8):CS49-55. PubMed ID: 16049385
[TBL] [Abstract][Full Text] [Related]
37. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?
Appelbaum FR
J Clin Oncol; 2004 Feb; 22(3):390-1. PubMed ID: 14691127
[No Abstract] [Full Text] [Related]
38. Isolated asymptomatic severe neutropenia as the presentation of myeloid/natural killer cell acute leukemia.
Rubio-Batllés M; de La Mata AC; Romero Macias JR; Vitaller AR
Haematologica; 2000 Mar; 85(3):322-4. PubMed ID: 10702827
[No Abstract] [Full Text] [Related]
39. Toxic epidermal necrolysis treated with intravenous immunoglobulin and granulocyte colony-stimulating factor.
Kalyoncu M; Cimsit G; Cakir M; Okten A
Indian Pediatr; 2004 Apr; 41(4):392-5. PubMed ID: 15123870
[TBL] [Abstract][Full Text] [Related]
40. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
